Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60,660,421
-
Total 13F shares
-
27,496,751
-
Share change
-
+1,868,350
-
Total reported value
-
$275,793,298
-
Put/Call ratio
-
3.3%
-
Price per share
-
$10.03
-
Number of holders
-
48
-
Value change
-
+$19,526,193
-
Number of buys
-
30
-
Number of sells
-
20
Institutional Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q3 2022
As of 30 Sep 2022,
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,496,751 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Deep Track Capital, LP, Sands Capital Ventures, LLC, Laurion Capital Management LP, GREAT POINT PARTNERS LLC, BlackRock Inc., COMMODORE CAPITAL LP, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.